首页 | 本学科首页   官方微博 | 高级检索  
检索        

益气解毒通络汤治疗自身免疫性肝病临床分析
引用本文:邹晓宁,许春,祖影,鞠莹.益气解毒通络汤治疗自身免疫性肝病临床分析[J].中国中医药现代远程教育,2021(4).
作者姓名:邹晓宁  许春  祖影  鞠莹
作者单位:沈阳市第六人民医院综合内二科
摘    要:目的探讨自拟益气解毒通络汤治疗自身免疫性肝病的临床疗效。方法选取2018年1月—2019年1月在沈阳市第六人民医院综合内二科就诊的80例自身免疫性肝病患者,随机分为试验组和对照组。对照组40例给予常规西医治疗,试验组40例在常规治疗的基础上使用自拟益气解毒通络汤,比较2组患者的临床有效率。结果试验组临床总有效率为95.0%(38/40),对照组临床总有效率为85.0%(34/40),试验组优于对照组,差异有统计学意义(P<0.05)。结论对自身免疫性肝病患者采取自拟益气解毒通络汤进行治疗,可以有效改善临床症状,提高生活质量,值得在临床推广。

关 键 词:益气解毒通络汤  自身免疫性病肝病  胁痛  中医药疗法

Clinical Analysis on Yiqi Jiedu Tongluo Decoction in the Treatment of Autoimmune Liver Disease
ZOU Xiaoning,XU Chun,ZU Ying,JU Ying.Clinical Analysis on Yiqi Jiedu Tongluo Decoction in the Treatment of Autoimmune Liver Disease[J].Chinese Medicine Modern Distance Education of China,2021(4).
Authors:ZOU Xiaoning  XU Chun  ZU Ying  JU Ying
Institution:(Department of General Internal Medicine,Shenyang Sixth People’s Hospital,Liaoning Province,Shenyang 110000,China)
Abstract:Objective To explore the clinical analysis of Yiqi Jiedu Tongluo decoction in the treatment of autoimmune liver disease.Methods 80 patients with autoimmune liver disease were selected,40 patients in the control group were treated with conventional western medicine,and 40 patients in the experimental group were treated with self-made Yiqi Jiedu Tongluo decoction on the basis of conventional treatment.Results The clinical effective rate of the experimental group was 95.0%(38/40),and that of the control group was 85.0%(34/40).The experimental group was better than the control group,and the difference was statistically significant(P<0.05).Conclusion Yiqi Jiedu Tongluo decoction is suitable for the treatment of autoimmune liver disease.
Keywords:Yiqi Jiedu Tongluo decoction  autoimmune liver diseases  hypochondriac pain  therapy of traditional Chinese medicine
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号